Search

Search Constraints

You searched for: Author/Creator Hong, S.

Search Results

37. Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, placebo‐controlled phase III trial. Issue 5 (18th March 2016)